We are live on
!
Find out more
RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$9.44B
1-Year Est. Return
68.42%
This Fund
S&P 500
This Quarter
Est. Return
-0.89%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$2.12B
AUM Growth
-$1.46B
(-41%)
Cap. Flow
-$1.39B
Cap. Flow
% of AUM
-65.63%
Top 10 Holdings %
Top 10 Hldgs %
43.15%
Holding
86
New
29
Increased
22
Reduced
6
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hertz
HTZ
|
+$237M |
| 2 |
Fluor
FLR
|
+$62.3M |
| 3 |
RDUS
Radius Health, Inc.
RDUS
|
+$48.2M |
| 4 |
Array Technologies
ARRY
|
+$44.1M |
| 5 |
Telesat
TSAT
|
+$43.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WillScot Mobile Mini Holdings
WSC
|
+$68.2M |
| 2 |
Ally Financial
ALLY
|
+$57.5M |
| 3 |
CF Industries
CF
|
+$46.3M |
| 4 |
LORL
Loral Space and Communications, Inc.
LORL
|
+$45.2M |
| 5 |
Green Plains
GPRE
|
+$43.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 26.57% |
| 2 | Healthcare | 18.85% |
| 3 | Technology | 10.3% |
| 4 | Consumer Discretionary | 9.18% |
| 5 | Energy | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Kiniksa Pharmaceuticals
KNSA
$6.09B
| – | – |
-153,618
| Closed | -$1.75M |
|
77
Kura Oncology
KURA
$875M
| – | – |
-400,000
| Closed | -$7.49M |
|
78
MGIC Investment
MTG
$6.29B
| – | – |
-1,521,006
| Closed | -$22.8M |
|
79
Ocular Therapeutix
OCUL
$2.24B
| – | – |
-354,728
| Closed | -$3.55M |
|
80
Radian Group
RDN
$4.86B
| – | – |
-938,368
| Closed | -$21.3M |
|
81
Rigel Pharmaceuticals
RIGL
$782M
| – | – |
-66,386
| Closed | -$2.41M |
|
82
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| – | – |
-2,500,000
| Closed | -$1.07B |
|
83
TripAdvisor
TRIP
$1.25B
| – | – |
-921,752
| Closed | -$31.2M |
|
|
HMHC
84
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| – | – |
-2,728,051
| Closed | -$36.6M |
|
|
LORL
85
DELISTED
Loral Space and Communications, Inc.
LORL
| – | – |
-1,050,000
| Closed | -$45.2M |
|
|
SBBP
86
DELISTED
Strongbridge Biopharma plc.
SBBP
| – | – |
-3,072,732
| Closed | -$6.27M |
|
Similar funds
RCM
SIM
NPT
AC
PVI
WPL
IAA
LAMI
Rubric Capital Management (New York)'s Q4 2021 Portfolio in Review
As of Q4 2021, Rubric Capital Management (New York) held 86 positions worth $2.12B, down 41% from $3.58B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Rubric Capital Management (New York) withdrew a net $1.39B in Q4 2021, closing 18 positions and reducing 6 holdings. Its most notable exit was Ally Financial, an estimated $57.5M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 6.3% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Rubric Capital Management (New York) opened a new position in Hertz worth $248M.
- Rubric Capital Management (New York)'s largest Q4 2021 buy was Hertz: 9,907,699 shares worth $248M.
- Rubric Capital Management (New York) added most to Radius Health, Inc. in Q4 2021, an estimated $48.2M increase.
- Rubric Capital Management (New York)'s biggest Q4 2021 reduction was WillScot Mobile Mini Holdings, cutting an estimated $68.2M.
- Rubric Capital Management (New York) fully exited Ally Financial in Q4 2021, selling an estimated $57.5M.
- Rubric Capital Management (New York)'s ten largest holdings make up 43% of its $2.12B portfolio in Q4 2021.
- Rubric Capital Management (New York) opened 29 new positions and closed 18 in Q4 2021.
- Rubric Capital Management (New York)'s portfolio value fell 41% quarter-over-quarter to $2.12B.
Based on Rubric Capital Management (New York)'s 13F filing for Q4 2021, filed 14 Feb 2022.